Key result
Sinoatrial node architecture dictates the source-sink balance required for normal pacemaking and biological pacemaker therapies.
The architecture of the sinoatrial node, including its unique intercellular coupling and electrophysiological gradients, is critical for maintaining the source-sink balance necessary for robust cardiac pacemaking and has implications for developing biological pacemakers.
Supports architecture-aware designs for biological pacemakers; leaves open validation of source-sink requirements in translational models.
Normal heart rhythm (sinus rhythm) depends on regular activity of the sinoatrial node (SAN), a heterogeneous collection of specialized myocytes in the right atrium. SAN cells, in general, possess a unique electrophysiological profile that promotes spontaneous electrical activity (automaticity). However, while automaticity is required for normal pacemaking, it is not necessarily sufficient. Less appreciated is the importance of the elaborate structure of the SAN complex for proper pacemaker function. Here, we review the important structural features of the SAN with a focus on how these elements help manage a precarious balance between electrical charge generated by the SAN ("source") and the charge needed to excite the surrounding atrial tissue ("sink"). We also discuss how compromised "source-sink" balance due, for example to fibrosis, may promote SAN dysfunction, characterized by slow and/or asynchronous pacemaker activity and even failure, in the setting of cardiovascular disease (e.g., heart failure, atrial fibrillation). Finally, we discuss implications of the "source-sink" balance in the SAN complex for cell and gene therapies aimed at creating a biological pacemaker as replacement or bridge to conventional electronic pacemakers.
No takes yet. Share an insight, caveat, or question.
Unudurthi et al. (2014) conducted a review in Sinoatrial node dysfunction. The structural architecture of the sinoatrial node is critical for maintaining the source-sink balance required for normal pacemaking, with implications for biological pacemaker therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: